Veterinary Medicine Information website

BUPROXAN MULTIDOSE 0.3 MG/ML SOLUTION FOR INJECTION FOR DOGS, CATS AND HORSES

Authorised
  • Buprenorphine hydrochloride

Product identification

Medicine name:
BUPROXAN MULTIDOSE 0.3 MG/ML SOLUTION FOR INJECTION FOR DOGS, CATS AND HORSES
Active substance:
  • Buprenorphine hydrochloride
Target species:
  • Dog
  • Cat
  • Horse (non food-producing)
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Buprenorphine hydrochloride
    0.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse (non food-producing)
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Clear colourless glass vial, 10 ml, Type I

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 134875
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0520/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Combined File of all Documents

English (PDF)
Published on: 9/04/2026
Download
Dutch (PDF)
Published on: 9/04/2026

eu-puar-frv0520001-mr-rpe1013-en.pdf

English (PDF)
Published on: 5/05/2026
Download